Mustafa Jaber, Asher Ilan, Sthoeger Zev
Department of Internal Medicine B, Kaplan Medical Center, Rehovot, affiliated with Hebrew University-Hadassah Medical School, Jerusalem, Israel.
Isr Med Assoc J. 2018 Jan;20(1):53-57.
Upper extremity deep vein thrombosis (UEDVT) is defined as thrombosis of the deep venous system (subclavian, axillary, brachial, ulnar, and radial veins), which drains the upper extremities. It can be caused by thoracic outlet anatomic obstruction, such as Paget-Schroetter syndrome, (primary) or by central intravenous catheters (secondary). UEDVT may be asymptomatic or present with acute severe pain and arm swelling. Clinical suspicion should be confirmed by diagnostic imaging procedures such as duplex ultrasound, computed tomography scan, or magnetic resonance imaging. UEDVT is managed by anticoagulant treatment. In addition to that, early thrombolysis aimed at preventing post-deep vein thrombosis syndrome and thoracic outlet decompression surgery should be given to patients with primary UEDVT. Anticoagulation without thrombolysis is the treatment of choice for patients with catheter-related thrombosis. Mandatory functioning catheters can remain in place with anticoagulant treatment. All other catheters should be immediately removed. The management of patients with UEDVT requires an experience multidisciplinary team comprised of internists, radiologists, hematologists, and vascular surgeons. Understanding the risk factors for the development of UEDVT, the diagnostic procedures, and the treatment modalities will improve the outcome of those patients.
上肢深静脉血栓形成(UEDVT)定义为上肢深静脉系统(锁骨下静脉、腋静脉、肱静脉、尺静脉和桡静脉)的血栓形成。它可由胸廓出口解剖学梗阻引起,如佩吉特-施罗特综合征(原发性),或由中心静脉导管引起(继发性)。UEDVT可能无症状,或表现为急性剧痛和手臂肿胀。临床怀疑应通过诊断性成像检查如双功超声、计算机断层扫描或磁共振成像来确诊。UEDVT通过抗凝治疗进行管理。除此之外,对于原发性UEDVT患者,应进行旨在预防深静脉血栓形成后综合征的早期溶栓治疗和胸廓出口减压手术。对于导管相关性血栓形成患者,不进行溶栓的抗凝治疗是首选治疗方法。强制性使用的功能性导管在抗凝治疗时可保留在位。所有其他导管应立即拔除。UEDVT患者的管理需要一个由内科医生、放射科医生、血液科医生和血管外科医生组成的经验丰富的多学科团队。了解UEDVT发生的危险因素、诊断程序和治疗方式将改善这些患者的治疗结果。